» Authors » Cornelius J J Westermann

Cornelius J J Westermann

Explore the profile of Cornelius J J Westermann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 559
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Orlova V, Nahon D, Cochrane A, Cao X, Freund C, van den Hil F, et al.
Stem Cell Reports . 2022 Jul; 17(7):1536-1545. PMID: 35777360
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease characterized by weak blood vessels. HHT1 is caused by mutations in the ENDOGLIN (ENG) gene. Here, we generated induced pluripotent stem cells...
2.
Letteboer T, Benzinou M, Merrick C, Quigley D, Zhau K, Kim I, et al.
Front Genet . 2015 Mar; 6:67. PMID: 25815003
HHT shows clinical variability within and between families. Organ site and prevalence of arteriovenous malformations (AVMs) depend on the HHT causative gene and on environmental and genetic modifiers. We tested...
3.
Kawasaki K, Freimuth J, Meyer D, Lee M, Tochimoto-Okamoto A, Benzinou M, et al.
Proc Natl Acad Sci U S A . 2014 May; 111(21):7723-8. PMID: 24812125
Outcome of TGFβ1 signaling is context dependent and differs between individuals due to germ-line genetic variation. To explore innate genetic variants that determine differential outcome of reduced TGFβ1 signaling, we...
4.
Benzinou M, Clermont F, Letteboer T, Kim J, Espejel S, Harradine K, et al.
Nat Commun . 2012 Jan; 3:616. PMID: 22233626
Hereditary haemorrhagic telangiectasia (HHT) [corrected] is a vascular dysplasia syndrome caused by mutations in transforming growth factor-β/bone morphogenetic protein pathway genes, ENG and ACVRL1. HHT [corrected] shows considerable variation in...
5.
van Laake L, van den Driesche S, Post S, Feijen A, Jansen M, Driessens M, et al.
Circulation . 2006 Nov; 114(21):2288-97. PMID: 17088457
Background: Endoglin, an accessory receptor for transforming growth factor-beta in vascular endothelial cells, is essential for angiogenesis during mouse development. Mutations in the human gene cause hereditary hemorrhagic telangiectasia type...
6.
Post M, Letteboer T, Mager J, Plokker T, Kelder J, Westermann C
Chest . 2005 Oct; 128(4):2485-9. PMID: 16236913
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal-dominant vascular dysplasia with a high prevalence of pulmonary arteriovenous malformation (PAVM). Recent studies report an increased prevalence of migraine in patients...
7.
Mager J, Overtoom T, Blauw H, Lammers J, Westermann C
J Vasc Interv Radiol . 2004 May; 15(5):451-6. PMID: 15126654
Purpose: To evaluate the long-term results of embolotherapy of pulmonary arteriovenous malformations (PAVMs) in a large group of patients. Materials And Methods: Between July 1988 and August 2001, 134 consecutive...
8.
Gallione C, Repetto G, Legius E, Rustgi A, Schelley S, Tejpar S, et al.
Lancet . 2004 Mar; 363(9412):852-9. PMID: 15031030
Background: Juvenile polyposis and hereditary haemorrhagic telangiectasia are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in MADH4...
9.
van den Driesche S, Mummery C, Westermann C
Cardiovasc Res . 2003 Apr; 58(1):20-31. PMID: 12667943
Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder in humans which has been mapped to two genes, endoglin and activin receptor-like kinase-1 (ALK-1) both of which mediate signaling by transforming...
10.
Westermann C, Rosina A, De Vries V, De Coteau P
Am J Med Genet A . 2003 Jan; 116A(4):324-8. PMID: 12522784
Hereditary hemorrhagic telangiectasia (HHT) has been reported rarely in people of African descent. The prevalence in the Afro-Caribbean population of the Netherlands Antilles is suspected to be high. A family...